Clinical trial
A Pilot Study of Silymarin During Maintenance Therapy in Children With Acute Lymphoblastic Leukemia (ALL)
NCT00055718 is registered in ClinicalTrials.gov with Herbert Irving Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Silymarin During Maintenance Therapy in Children With Acute Lymphoblastic Leukemia (ALL)
- Lead sponsor
- Herbert Irving Comprehensive Cancer Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2001
- Completion date
- January 31, 2010
- Enrollment
- 50 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
drug/agent toxicity by tissue/organ, leukemia